Question 1

What are the potential side effects of SKB571?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of SKB571 in Patients With Lung Cancer clinical trial (NCT07230405). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of SKB571 in Patients With Lung Cancer clinical trial (NCT07230405). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of SKB571 in Patients With Lung Cancer clinical trial (NCT07230405). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of SKB571 in Patients With Lung Cancer clinical trial (NCT07230405). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific risks I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of SKB571 in Patients With Lung Cancer clinical trial (NCT07230405). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience intolerable side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of SKB571 in Patients With Lung Cancer clinical trial (NCT07230405). Contact the study team or your healthcare provider for specific answers.

What this study is about